Table 1 Characteristics of the baseline and intervention measurement cohorts
Characteristic | Baseline measurement (n = 250) | Intervention measurement (n = 250) | P value* |
|---|---|---|---|
Age, mean in years ± SD in years | 76.9 ± 7.5 | 77.2 ± 7.9 | 0.655 |
Female, n (%) | 133 (53.2) | 124 (49.6) | 0.421 |
Living independently, n (%) | 211 (84.4) | 196 (78.4) | 0.085 |
Type of admission: acute admission, n (%) | 213 (85.2) | 223 (89.2) | 0.181 |
Time of admission: weekday admission, n (%) | 140 (56.0) | 168 (67.2) | 0.010 |
Length of staya, median; IQR | 5.9; 6.0 | 6.0; 8.1 | 0.778 |
Number of preadmission medications, mean ± SD | 7.31 ± 3.2 | 7.85 ± 3.7 | 0.084 |
Number of hospital medications, mean ± SD | 11.0 ± 4.1 | 12.7 ± 5.0 | < 0.001 |
Charlson Co-morbidity Index score, mean ± SD | 2.78 ± 2.0 | 2.87 ± 1.9 | 0.613 |
Number of concomitant diseases, mean ± SD | 3.16 ± 1.7 | 3.39 ± 1.9 | 0.150 |
Cognitive impairment on admissionb, n (%) | 45 (18.0) | 52 (20.8) | 0.429 |
MDRD eGFRc (ml/min/1.73 m2), n (%) | n = 240 | n = 245 | 0.946 |
≥ 60 | 94 (39.2) | 93 (38.0) | |
30–59 | 89 (37.1) | 91 (37.1) | |
≤ 29 | 57 (23.8) | 61 (24.9) |